Amigues et al. Zoledronate related ONJ. French pharmacovigilance database. Rare with rheumatic (vs onc) use but higher than with risedronate or alendronate. Incidence 9.6 vs 2 vs 5.1 /100000 @RheumNow #EULAR2022 OP0240 https://t.co/SCYiyJF76S